Blog

Future Oncology Dossiers: AOD Acceleration, Adaptive Design & Safety

{ "content": "Future oncology dossiers must be built for speed and adaptability without sacrificing regulatory rigor. This guide gives practical, implementation-focused steps to align adaptive designs, eConsent, dossier readiness, and post-approval safety planning for modern breast and broader ...

Expert Guide: Federated Analytics & EHR Endpoints for Oncology Trials

How federated analytics and EHR endpoints are reshaping oncology trials: from privacy-preserving multi-site models to analytics-driven elderly recruitment in NYC and EHR-derived outcomes in HR+ breast cancer.

Optimizing HR+ Breast Cancer Trials: Remote Monitoring, Consent & Cost

Data-driven trends show hybrid remote monitoring, low-literacy eConsent, and proactive financial mitigation will reshape HR+ breast cancer trials—boosting retention, safety and diversity.

Data-Driven Trial Equity: HR+ Breast, Rural Glaucoma, HN SCC & Spanish

{ "content": "Clinical research is at an inflection point where precision science meets access equity. Recent analyses show breast cancer subtype trials, glaucoma studies, and head and neck squamous cell carcinoma (HN SCC) research are all being reassessed for inclusion gaps — and the data are ...

Guide to Seasonal Enrollment, HR+ Elderly Economics & Remote Glaucoma

A focused guide for sites and sponsors on seasonal enrollment effects, the economics of enrolling older HR+ breast cancer patients, and adoption of decentralized methods in glaucoma trials—grounded in recent trial experience and regulatory updates.

Expert Strategies: Equitable NYC Elderly, HR+ Breast, H&N & Flu

Practical strategies for equitable enrollment of NYC seniors, inclusive HR+ breast cancer trials, culturally adapted H&N recruitment, and diverse flu-season healthy volunteers—designed for study teams and pharmaceutical project managers.

Predicting Trial Care: Home Derm Side-Effect Tactics & HNSCC Alerts

{ "content": "Clinical trial participants and study teams need practical, site-proof tactics when side effects and seasonal risks intersect with care delivered at home. This guide breaks down what to do for atopic dermatitis managed at home and how to spot and report immune-related changes in h...

What will HNSCC investments and HR+ shifts mean for NYC trials in flu?

How do HNSCC investments and HR+ shifts affect NYC flu-season trials? Expect resource reallocation, enrollment seasonality, and special considerations for elderly and treatment-resistant patients—plus practical steps to improve participation.

Guide to Hormone-Positive Trial Choices, Fertility & Vaccines

Practical Q&A on hormone-positive trial choices, fertility preservation, spironolactone studies for hair loss/acne, and vaccine safety in pregnancy—plus caregiver insights and market research-driven guidance.